Your browser doesn't support javascript.
loading
Increasing age predicts adverse pathology including intraductal carcinoma of the prostate and cribriform patterns in deferred radical prostatectomy after upfront active surveillance for Gleason grade group 1 prostate cancer: analysis of prospective observational study cohort.
Tohi, Yoichiro; Ishikawa, Ryou; Kato, Takuma; Miyakawa, Jimpei; Matsumoto, Ryuji; Mori, Keiichiro; Mitsuzuka, Koji; Inokuchi, Junichi; Matsumura, Masafumi; Shiga, Kenichiro; Naito, Hirohito; Kohjimoto, Yasuo; Kawamura, Norihiko; Inoue, Masaharu; Akamatsu, Shusuke; Terada, Naoki; Miyazawa, Yoshiyuki; Narita, Shintaro; Haba, Reiji; Sugimoto, Mikio.
Afiliación
  • Tohi Y; Department of Urology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
  • Ishikawa R; Department of Diagnostic Pathology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
  • Kato T; Department of Urology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
  • Miyakawa J; Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Matsumoto R; Department of Renal and Genito-Urinary Surgery, Graduate School of Medicine, Hokkaido University, Hokkaido, Japan.
  • Mori K; Department of Urology, Jikei University School of Medicine, Tokyo, Japan.
  • Mitsuzuka K; Department of Urology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
  • Inokuchi J; Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Matsumura M; Department of Urology, National Hospital Organization Shikoku Cancer Center, Ehime, Japan.
  • Shiga K; Division of Urology, Harasanshin Hospital, Fukuoka, Japan.
  • Naito H; Department of Urology, Kurashiki Central Hospital, Okayama, Japan.
  • Kohjimoto Y; Department of Urology, Wakayama Medical University, Wakayama, Japan.
  • Kawamura N; Department of Urology, Osaka International Cancer Institute, Osaka, Japan.
  • Inoue M; Department of Urology, Saitama Cancer Center, Saitama, Japan.
  • Akamatsu S; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Terada N; Department of Urology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
  • Miyazawa Y; Department of Urology, Gunma University Graduate School of Medicine, Gunma, Japan.
  • Narita S; Department of Urology, Akita University School of Medicine, Akita, Japan.
  • Haba R; Department of Diagnostic Pathology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
  • Sugimoto M; Department of Urology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Jpn J Clin Oncol ; 53(10): 984-990, 2023 Oct 04.
Article en En | MEDLINE | ID: mdl-37496400
ABSTRACT

BACKGROUND:

In men undergoing upfront active surveillance, predictors of adverse pathology in radical prostatectomy specimens, including intraductal carcinoma of the prostate and cribriform patterns, remain unknown. Therefore, we aimed to examine whether adverse pathology in radical prostatectomy specimens could be predicted using preoperative patient characteristics.

METHODS:

We re-reviewed available radical prostatectomy specimens from 1035 men prospectively enrolled in the PRIAS-JAPAN cohort between January 2010 and September 2020. We defined adverse pathology on radical prostatectomy specimens as Gleason grade group ≥3, pT stage ≥3, pN positivity or the presence of intraductal carcinoma of the prostate or cribriform patterns. We also examined the predictive factors associated with adverse pathology.

RESULTS:

All men analyzed had Gleason grade group 1 specimens at active surveillance enrolment. The incidence of adverse pathologies was 48.9% (with intraductal carcinoma of the prostate or cribriform patterns, 33.6%; without them, 15.3%). The addition of intraductal carcinoma of the prostate or cribriform patterns to the definition of adverse pathology increased the incidence by 10.9%. Patients showing adverse pathology with intraductal carcinoma of the prostate or cribriform patterns had lower biochemical recurrence-free survival (log-rank P = 0.0166). Increasing age at active surveillance enrolment and before radical prostatectomy was the only predictive factor for adverse pathology (odds ratio 1.1, 95% confidence interval 1.02-1.19, P = 0.0178; odds ratio 1.12, 95% confidence interval 1.02-1.22, P = 0.0126).

CONCLUSIONS:

Increasing age could be a predictive factor for adverse pathology. Our findings suggest that older men could potentially derive advantages from adhering to the examination schedule in active surveillance.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Carcinoma Intraductal no Infiltrante Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Humans / Male Idioma: En Revista: Jpn J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Carcinoma Intraductal no Infiltrante Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Humans / Male Idioma: En Revista: Jpn J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Japón